These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 8318993)

  • 21. Familial defective apolipoprotein B-100.
    Hansen PS
    Dan Med Bull; 1998 Sep; 45(4):370-82. PubMed ID: 9777289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of low density lipoprotein receptor function and gene mutation in familial hypercholesterolemic patients].
    Guan X; Li M; Fan L; Chen Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):138-42. PubMed ID: 12673584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetics of hypercholesterolamemia: the detection of mutations in the apolipoprotein B gene using denaturing gradient gel electrophoresis.
    Gaffney D; Reid JM; Vass K; Packard CJ
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():19-20. PubMed ID: 8767449
    [No Abstract]   [Full Text] [Related]  

  • 24. [Screening for the new variant of defective receptor-binding apolipoprotein B-100].
    Li Y; Feng J; Li W
    Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(23):1434-5. PubMed ID: 11930615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Familial defect of apo B-100 in subjects with clinically diagnosed primary hypercholesterolemia: identification of the first family with this disorder in Spain].
    Real JT; Chaves JF; Ascaso JF; Armengod ME; Carmena R
    Med Clin (Barc); 1999 Jun; 113(1):15-7. PubMed ID: 10422071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Origin and migration of an Afrikaner founder mutation FHAfrikaner-2 (V408M) causing familial hypercholesterolemia.
    Defesche JC; Van Diermen DE; Hayden MR; Kastelein JP
    Gene Geogr; 1996 Apr; 10(1):1-10. PubMed ID: 8913716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the Afrikaner mutation in exon 9 of the low-density lipoprotein receptor gene in a large Dutch kindred suffering from familial hypercholesterolaemia.
    Defesche JC; Lansberg PJ; Reymer PW; Lamping RJ; Kastelein JJ
    Neth J Med; 1993 Feb; 42(1-2):53-60. PubMed ID: 8446226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FH clinical phenotype in Greek patients with LDL-R defective vs. negative mutations.
    Dedoussis GV; Skoumas J; Pitsavos C; Choumerianou DM; Genschel J; Schmidt H; Stefanadis C
    Eur J Clin Invest; 2004 Jun; 34(6):402-9. PubMed ID: 15200491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel mutation in the caveolin-3 gene causing familial isolated hyperCKaemia.
    Alias L; Gallano P; Moreno D; Pujol R; Martínez-Matos JA; Baiget M; Ferrer I; Olivé M
    Neuromuscul Disord; 2004 May; 14(5):321-4. PubMed ID: 15099591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for mutations in the LDL receptor gene and apolipoprotein B-100 gene in 218 patients with severe hypercholesterolemia.
    Geisel J; Holzem G; Schleifenbaum T; Oette K
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():14-5. PubMed ID: 8767447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation analysis in familial hypercholesterolemia patients of different ancestries: identification of three novel LDLR gene mutations.
    Callis M; Jansen S; Thiart R; de Villiers JN; Raal FJ; Kotze MJ
    Mol Cell Probes; 1998 Jun; 12(3):149-52. PubMed ID: 9664576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of mutations and genetherapy. Clinical genetics of familial hypercholesterolemia.
    Schuster H
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():4-5. PubMed ID: 8767443
    [No Abstract]   [Full Text] [Related]  

  • 33. Approach to identification of a point mutation in apo B100 gene by means of a PCR-mediated site-directed mutagenesis.
    Schwartz EI; Shevtsov SP; Kuchinski AP; Kovalev YuP ; Plutalov OV; Berlin YuA
    Nucleic Acids Res; 1991 Jul; 19(13):3752. PubMed ID: 1852619
    [No Abstract]   [Full Text] [Related]  

  • 34. A polymorphism in a region with enhancer activity in the second intron of the human apolipoprotein B gene.
    Levy-Wilson B; Soria L; Ludwig EH; Argyres M; Brooks AR; Blackhart BD; Friedl W; McCarthy BJ
    J Lipid Res; 1991 Jan; 32(1):137-45. PubMed ID: 2010685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of gene probes to investigate the etiology of hyperlipidaemia and arterial diseases.
    Humphries SE
    Acta Cardiol Suppl; 1988; 29():85-95. PubMed ID: 2898851
    [No Abstract]   [Full Text] [Related]  

  • 36. [Epidemiology and molecular genetics of atherosclerosis].
    Cambien F; De Tand MF; Moreel JF
    Ann Cardiol Angeiol (Paris); 1991 May; 40(5):231-6. PubMed ID: 1859121
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hyperlipoproteinemia IIa: report of a family].
    Ghigna I; Riva C; Brunet MR; Pontarollo F; Navone M; Migliore G; Nigro N; Musso A
    Minerva Pediatr; 1985 Oct; 37(19):721-7. PubMed ID: 3937041
    [No Abstract]   [Full Text] [Related]  

  • 38. The proper study of mankind.
    Robertson M
    Nature; 1986 Jul 3-9; 322(6074):11. PubMed ID: 3724848
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetic illness in the adult ICU: implications for nursing practice.
    Schutte D
    Crit Care Nurse; 1995 Jun; 15(3):49-56. PubMed ID: 7774270
    [No Abstract]   [Full Text] [Related]  

  • 40. Long runs of adenines and human mutations.
    Raabe M; Linton MF; Young SG
    Am J Med Genet; 1998 Feb; 76(1):101-2. PubMed ID: 9508075
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.